Earnings History Data for Ventyx Biosciences (VTYX) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Ventyx Biosciences
Ventyx Biosciences Inc. is a clinical-stage biopharmaceutical company. It focused on advancing new therapies for patients living with inflammatory diseases and autoimmune disorders. The company's clinical stage pipeline includes VTX958, VTX002 and VTX2735. Ventyx Biosciences Inc. is headquartered in Encinitas, California.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 27-02-2024 | PM | VTYX | Ventyx Biosciences | 396.00 | -0.79 | -0.78 | 0.00 | Ventyx Biosciences GAAP EPS of -$0.79 [2/28/2024 1:32 AM] |
7.74 | 1.69 (27.85%) |
6.59 | 0.54 (8.93%) |
1.87 - 47.25 | 15,199,685 | 13,900,000 | 223,747 | ||
| 10-08-2023 | AH | VTYX | Ventyx Biosciences, Inc. | 1,940 | -0.91 | -0.71 | -0.39 | Ventyx Biosciences GAAP EPS of -$0.91 misses by $0.20 [8/10/2023 4:50 PM] |
33.29 | -1.58 (-4.53%) |
34.87 | 0.0 (0.00%) |
16.75 - 47.25 | 1,144,871 | 500,000 | 9,895 | ||
| 11-05-2023 | AH | 4:00 PM ET (May 11) |
VTYX | Ventyx Biosciences, Inc. | 2,280 | -0.68 | -0.64 | -0.45 | Ventyx Biosciences GAAP EPS of -$0.68 misses by $0.03 [5/11/2023 4:14 PM] |
34.67 | -2.90 (-7.71%) |
37.57 | 0.0 (0.00%) |
11.07 - 47.25 | 839,801 | 600,000 | 246,928 | |
| 23-03-2023 | AH | 4:00 PM ET (Mar 23) |
VTYX | Ventyx Biosciences, Inc. | 2,420 | -0.62 | -0.59 | 0.00 | Ventyx Biosciences GAAP EPS of -$0.62 beats by $0.02 [3/23/2023 4:04 PM] |
34.45 | -2.06 (-5.64%) |
36.51 | 0.0 (0.00%) |
10.75 - 47.25 | 1,379,866 | 1,080,000 | 4,392 | |
| 03-11-2022 | AH | 4:05 PM ET (Nov 3) |
VTYX | Ventyx Biosciences, Inc. | 1,900 | -0.59 | -0.45 | -3.17 | Ventyx Biosciences GAAP EPS of -$0.59 misses by $0.15 [11/3/2022 4:56 PM] |
29.09 | -3.62 (-11.08%) |
32.71 | 0.0 (0.00%) |
9.50 - 41.29 | 385,294 | 310,000 | 1,048 | |
| 15-08-2022 | AH | 4:00 PM ET (Aug 15) |
VTYX | Ventyx Biosciences, Inc. | 758.69 | -0.39 | -0.47 | 0.00 | Ventyx Biosciences GAAP EPS of -$0.39 beats by $0.06 [8/15/2022 4:11 PM] |
24.61 | 6.01 (32.31%) |
21.34 | 2.74 (14.73%) |
9.50 - 27.65 | 1,955,821 | 230,000 | 327 | |
|
||||||||||||||||||
| 12-05-2022 | AH | 4:10 PM ET (May 12) |
VTYX | Ventyx Biosciences, Inc. | 735.63 | -0.45 | -0.37 | 0.00 | Ventyx Biosciences GAAP EPS of -$0.45 beats by $0.07 [5/12/2022 4:30 PM] |
14.84 | 0.31 (2.13%) |
14.53 | 0.0 (0.00%) |
9.50 - 26.00 | 148,034 | 130,000 | 1,211 | |